Comparison of Effectiveness of Topiramate and Diazepam in Preventing Risk of Recurrent Febrile Seizure in Children underAge of 2 Years
Iranian Journal of Child Neurology,
Vol. 12 No. 3 (2018),
26 June 2018
,
Page 69-77
https://doi.org/10.22037/ijcn.v12i3.12981
Abstract
Background and Objective: Febrile seizures are the most common type of convulsions. Medicinal prophylaxis is sometimes used for children at high risk of recurrent febrile seizure. In certain circumstances, conventional drugs such as diazepam and phenobarbital cannot be used and the need for alternative medicines is felt. This study set out to compare the effectiveness of topiramate and diazepam in preventing the risk of recurrent febrile seizure in children under the age of 2 years.
Methodology: This was a randomized controlled trial. The research sampleincluded 54 patients, at risk of recurrent febrile seizure,who were inhibited from taking phenobarbital. After selection, they were randomly divided into two groups. The first group received diazepam treatment during fever episodes and the second group received daily dose of topiramate. A one-year follow-up of recurrent febrile seizure and its complications was also conducted.
Findings: Thirty four patients (17 patients in each group) completed the one-year course of the trial. Recurrent febrile seizure was not observed in the course of preventive treatment. The prevalence of minor complications was 29.4% in the diazepam group and 48.5% in the topiramate group.No major complication was observed in among the subjects
Conclusion: Topiramate can be recommended for preventing recurrent febrile seizure when the use of front line medicines is not possible.
- Febrile Seizure
- Prevention
- Diazepam
- Topiramate
How to Cite
References
Chung S. Febrile seizures. Korean journal of pediatrics. 2014;57 (9):384-95.
Swaiman KF, Ashwal S, Ferriero DM, Schor NF. Swaiman's pediatric neurology: principles and practice: Elsevier Health Sciences; 2012.
Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures. Febrile Seizures: Clinical Practice Guideline for the Long-term Management of the Child With Simple Febrile Seizures .Pediatrics 2008;121:1281–1286
Hirtz DG. Generalized tonic-clonic and febrile seizures. Pediatric clinics of North America. 1989;36 (2):365-82.
Shlomo Shinnar. Febrile Seizures and Mesial Temporal Sclerosis.Epilepsy Curr. 2003 Jul; 3(4): 115–118.
Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM, et al. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. New England Journal of Medicine. 1993;329 (2):79-84.
Sugai K. Current management of febrile seizuresin Japan: an overview. Brain and Development. 2010;32 (1):64-70.
Lux AL. Treatment of febrile seizures: historical perspective, current opinions, and potential future directions. Brain & development. 2010;32 (1):42-50.
Tonekaboni S, Beyraghi N, Barzegar M, Vesal A. Comparison between Diazepam and Phenobarbital in prevention of febrile seizure. Iranian Journal of Pediatrics. 2005;15 (2):145-50.
Darreh F, Kahbazi M. Comparing the effect of intermittent Diazepam and continuous Phenobarbital in prophylaxis of recurrence of febrile seizure. Arak Medical University Journal. 2008;11 (2):35-41.
Bernstein D, Shelov SP. Pediatrics for medical students: Lippincott Williams & Wilkins; 2003.Epilepsy in children. 3rd ed. 2004. p 12-23
Duffner P, Baumann R, Green J. Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures. American Academy of Pediatrics. Steering Committee on Quality Improvement and Management. Subcommittee of Febrile Seizures. Pediatrics. 2008;121 (6):1281-6.
Kliegman RM, Stanton B, Geme JS, Schor NF, Behrman RE. Nelson textbook of pediatrics. 20, editor: Elsevier Health Sciences; 2016.
Shinnar S, Glauser TA. Febrile seizures. Journal of child neurology. 2002;17 (1 suppl):S44-S52.
Waruiru C, Appleton R. Febrile seizures: an update. Archives of disease in childhood. 2004;89 (8):751-6.
Qiu P-L, Shi Y, Sun D-K, Wang Y. Clinical and EEG features in children with febrile seizures after antiepileptic drug therapy. Zhongguo dang dai er keza zhi= Chinese journal of contemporary pediatrics. 2011;13 (2):123-6.
Sendrowski K, Sobaniec W, Sobaniec-Lotowska ME, Artemowicz B. Topiramate as a neuroprotectant in the experimental model of febrile seizures. Therapeutic-nursing problems since born to old age. 2007;52:161.
Lotowska JM, Sobaniec-Lotowska ME, Sendrowski K, Sobaniec W, Artemowicz B. Ultrastructure of the blood-brain barrier of the gyrus hippocampal cortex in an experimental model of febrile seizures and with the use of a new generation antiepileptic drug-topiramate. Folia Neuropathologica. 2008;46 (1):57.
Knudsen FU, Vestermark S. Prophylactic diazepam or phenobarbitone in febrile convulsions: a prospective, controlled study. Archives of disease in childhood. 1978;53 (8):660-3.
Beyraghi N, Hatamian B, Vesal A, Tonekaboni S. Comparison between diazepam and phenobarbital in prevention of febrile seizure: clinical trial. Iranian Journal of Child Neurology. 2008;2 (3):37-40.
Badv R, Aharchi B, Kamali K. Nitrazepam Versus Diazepam as Intermittent Prophylaxis for Febrile SeizuresZUMS Journal2013;21 (89):10-6.
Amouian S, JALILI AM, Arabi M. Comparing Clobazam with Diazepam in Preventing Febrile Seizure in Children: A Randomized Clinical Trial. 2014.
Autret E, Billard C, Bertrand P, Motte J, Pouplard F, Jonville AP. Double-blind, randomized trial of diazepam versus placebo for prevention of recurrence of febrile seizures. The Journal of Pediatrics. 1990;117 (3):490-4.
Hemmati M, Rezaei M. The effect of different oral dose Diazepam on preventing seizure in Febrile Convulsion. Journal of Kermanshah University of Medical Sciences(J Kermanshah Univ Med Sci). 2012;16 (2):87-91.
Costa M, Silva EA, Silva AE, Guerreiro MM. [Intermittent prophylaxis in febrile seizures with oral diazepam: study of 82 cases]. Arq Neuropsiquiatr. 1996;54 (2):197-201.
.Guerreiro MM, Costa M, Bellomo MA, Sabino SH, Silva EA, Scotoni AE. Intermittent prophylaxis in febrile seizures with oral diazepam. Arquivos de Neuro-psiquiatria. 1992;50 (2):163-7.
Daugbjerg P, Brems M, Mai J, Ankerhus J, Knudsen F. Intermittent prophylaxis infebrile convulsions: diazepam or valproic acid? Acta Neurologica Scandinavica. 1990;82 (1):17-20.
Mula M, Trimble MR, Lhatoo SD, Sander JW. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia. 2003;44 (5):659-63.
Grosso S, Galimberti D, Farnetani M, Cioni M, Mostardini R, Vivarelli R, et al. Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure. 2005;14 (3):183-9.
Al Ajlouni S, Shorman A, Daoud A. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial. Seizure. 2005;14 (7):459-63.
Giannakodimos ST, Georgiadis G, Tsounis ST, Triantafillou N, Kimiskidis V, Giatas K, et al. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals. Seizure. 2005;14 (6):396-402.
- Abstract Viewed: 293 times